These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies. Watkins RR Expert Rev Anti Infect Ther; 2018 Aug; 16(8):591-593. PubMed ID: 30024320 [No Abstract] [Full Text] [Related]
6. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070 [No Abstract] [Full Text] [Related]
7. Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand. Thamlikitkul V; Tiengrim S; Seenama C Int J Antimicrob Agents; 2016 Jan; 47(1):101-2. PubMed ID: 26725031 [No Abstract] [Full Text] [Related]
8. In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. Thamlikitkul V; Tiengrim S Int J Antimicrob Agents; 2013 Sep; 42(3):284-5. PubMed ID: 23876336 [No Abstract] [Full Text] [Related]
10. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
11. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units. Ozbek B; Otük G Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868 [No Abstract] [Full Text] [Related]
12. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates. Nepka M; Perivolioti E; Kraniotaki E; Politi L; Tsakris A; Pournaras S Antimicrob Agents Chemother; 2016 Nov; 60(11):6903-6906. PubMed ID: 27550356 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972 [TBL] [Abstract][Full Text] [Related]
14. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Poirel L; Nordmann P Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287 [TBL] [Abstract][Full Text] [Related]
15. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates. Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates. Ozger HS; Cuhadar T; Yildiz SS; Demirbas Gulmez Z; Dizbay M; Guzel Tunccan O; Kalkanci A; Simsek H; Unaldi O J Antibiot (Tokyo); 2019 Aug; 72(8):600-604. PubMed ID: 31028352 [TBL] [Abstract][Full Text] [Related]
17. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of an automated system for the detection of carbapenem resistant Acinetobacter baumannii and assessment of metallo-β-lactamase production using two different phenotyping methods. Aybey AD; Aksit F; Oz Y; Kiremitci A; Durmaz G J Microbiol Methods; 2011 Jul; 86(1):121-3. PubMed ID: 21530594 [TBL] [Abstract][Full Text] [Related]
19. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. Fan B; Guan J; Wang X; Cong Y PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]